We are delighted to announce that our recent research (link), published in JCI Insight, has received recognition in the Lancet Hematology (link). Our study sheds light on a fascinating discovery, revealing that women undergoing chemotherapy may experience greater benefits when the treatment is administered in the afternoon, as opposed to the morning.